Describe the results of recent clinical trials in heart failure and discuss their clinical implications.

Speaker Objective(s):

Follow-Up Results from AUGMENT-HF: A Multicenter Randomized Controlled Clinical Trial of the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Heart Failure
Commentary
HeartMate 3 CE Mark Clinical Study
Commentary (HeartMate 3)
Commentary (NECTAR-HF)
Aquarpheresis Versus Diuretics and Hospitalization for Heart Failure Trial (AVOID HF)
CUPID 2: A Phase 2b Trial Investigating the Efficacy and Safety of the Intracoronary Administration of AAV1/SERCA2a in Patients with Advanced Heart Failure
Commentary (CUPID 2)
ENCORE Study
Commentary (ENCORE)
Neural Cardiac Therapy for Heart Failure (NECTAR-HF)
Commentary (AVOID-HF)

Douglas Mann MD, PhD

Washington University at St. Louis School of Medicine